在患有抑郁症的患者中,可解释的多式预测治疗耐药性,利用大脑形态学和自然语言处理
Dong Yun Lee1, Narae Kim2, ChulHyoung Park1
1Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, South Korea; Department of Medical Sciences, Graduate School of Ajou University, Suwon, South Korea.
Psychiatry research
|March 2, 2024
概括
预测耐治疗抑郁症 (TRD) 很困难. 结合电子健康记录,脑部MRI和临床笔记,显著提高了TRD预测的准确性.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 医疗信息学 医疗信息学
背景情况:
- 20%的抑郁症患者在当前的治疗方法下无法实现缓解.
- 预测耐治疗抑郁症 (TRD) 是一个重大的临床挑战.
研究的目的:
- 为TRD开发一个可解释的多式联运预测模型.
- 整合结构化的电子病历 (EMR) 数据,脑形态测量 (MRI) 和临床笔记的自然语言处理 (NLP).
主要方法:
- 开发了使用极端梯度提升 (XGBoost) 和五倍交叉验证的TRD预测模型.
- 综合表格式EMR特征,脑T1加权的MRI独立组件重量和临床笔记主题概率.
- 包括247名患有新的抑郁情节的患者.
主要成果:
- 集成所有数据源的多式模式在接收器操作特征 (AUROC) 下获得了最高的面积,为0.794.4.
- 结合脑部MRI和结构化数据 (0.770) 和脑部MRI与临床笔记 (0.762) 的模型也显示出强大的预测性能.
- 关键预测因素包括药物史,感官运动网络,默认模式网络活动和体征症状.
结论:
- 将临床数据与神经成像和NLP变量集成,可以提高TRD预测.
- 多模式方法为识别TRD风险患者提供了一个有希望的策略.
- 可解释的AI模型可以提供对TRD预测驱动因素的见解.
相关概念视频
Brain Imaging
229
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
229
Antidepressant Drugs: MAOIs and Other Agents
229
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
229


